Kytopen’s Post

We had a great time at this year's Meeting on the Mesa 2024 in Phoenix, Arizona! Thanks for the fruitful conversations and meetings. If you have any questions or would like to continue our conversation contact us https://lnkd.in/g8cqzu72 #CGMesa24 #MeetingontheMesa #regenerativemedicine #celltherapy #CGT #nonviral #geneediting #CART

We're excited to participate in the 7th International Conference on CRISPR Technologies Laurén Kinner, Director of Field Applications, will present Maximizing Yields of Highest Quality Cells with Flowfect at Session 6: Delivery Modalities Oct. 15 at 3:55 PM. To learn more: https://lnkd.in/g_hVUvgT or contact us https://lnkd.in/g8cqzu72 #CRISPR #innovation #tcells #NKcells #regenerativemedicine #geneediting

We are excited to be at the Cell & Gene Meeting on the Mesa this week in Phoenix, AZ. There is still time to book a meeting with our team: https://lnkd.in/eFuAxjgQ to learn how Kytopen’s Flowfect™ technology will accelerate the development and manufacture of the highest quality advanced cell therapies. Or contact us: or contact us https://lnkd.in/g8cqzu72 #CGMesa24 #MeetingontheMesa #regenerativemedicine #celltherapy #CGT #nonviral #geneediting #CART

We are headed to the Cell & Gene Meeting on the Mesa next week, Oct. 7-9, 2024 in Phoenix, AZ. Book a meeting with our team: https://lnkd.in/eFuAxjgQ to learn how Kytopen’s Flowfect™ technology will accelerate the development and manufacture of the highest quality advanced cell therapies. Or contact us: https://lnkd.in/g8cqzu72 #CGMesa24 #MeetingontheMesa #regenerativemedicine #celltherapy #CGT #nonviral #geneediting #CART

Join us at the 7th International Conference on CRISPR Technologies Laurén Kinner, PhD, Director of Field Applications will present: Maximizing Yields of Highest Quality Cells with Flowfect  Session 6: Delivery Modalities Oct. 15 at 3:55 PM To learn more: https://lnkd.in/g_hVUvgT or contact us https://lnkd.in/g8cqzu72 #CRISPR #innovation #regenerativemedicine #geneediting

We are excited to join industry leaders at the Cell & Gene Meeting on the Mesa, Oct. 7-9, 2024 in Phoenix, AZ. Book a meeting with our team: https://lnkd.in/eFuAxjgQ to learn how Kytopen’s Flowfect™ technology will accelerate the development and manufacture of the highest quality advanced cell therapies. Or contact us: https://lnkd.in/g8cqzu72  #CGMesa24 #celltherapy #regenerativemedicine #tcells #cancer #cancerresearch #geneediting #innovation

We're #hiring - Head of Science in Cambridge, MA. Apply today or share this post with your network. https://lnkd.in/egjnS3ha

We had a great time at the CAR-TCR Summit 2024! If you missed it, check out our poster here: https://lnkd.in/gJb-FkZN #celltherapy #CART #TCR #CARTCR #nonviral #cellandgenetherapy #cancerresearch #geneediting

We are thrilled to announce the publication of a 10-day study conducted by Charles River, comparing Kytopen’s Flowfect Tx™ cellular engineering platform with two commercially available electroporation platforms. A key finding in this study was the considerably higher yields of gene-edited, viable cells with the Flowfect Tx™ platform. “We have a GMP-scale manufacturing platform that has already been evaluated for tech transfer and this study further highlights the ease of implementation to develop superior yields of final drug substance", said Kevin Gutshall, Chief Commercial Officer at Kytopen. To access the full press release: https://lnkd.in/gJnfCgMX To access the summary of the study, Making Gains in Non-Viral Engineering of T Cells for Cell Manufacturing, visit https://bit.ly/3ANGxxF  #celltherapy #regenerativemedicine #tcells #cancer #cancerresearch #geneediting #innovation

Visit Poster #16 - Our Vice President of BD & Sales will be in Boston tomorrow to present during the Welcome Session at the CAR-TCR Summit. #CARTCR 📅 Tuesday, Sept. 17th at 6:00 pm ET 📍 The Welcome Session, Poster #16, Hynes Convention Center Meet with us to learn about A Non-Viral Pathway to GMP Manufacture Engineered Cell Therapies to Maximize Yields of Highest Quality Cells - using Kytopen's Flowfect™ technology https://lnkd.in/ehu6JBBQ or contact us https://lnkd.in/g8cqzu72 #celltherapy #CART #TCR #CARTCR #nonviral #cellandgenetherapy #cancerresearch #geneediting